Showing results (121-130 of 222) with videos related to

Sort By:
Pageof 23
The British Journal of Dermatology|June 24, 2006
CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trialL Dubertret, W Sterry, J D Bos, et al.
The British Journal of Dermatology|March 29, 2014
Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practiceN H Shear, M Hartmann, M Toledo-Bahena, et al.
Prenatal Diagnosis|March 12, 1999
Prenatal diagnosis of hepatic mesenchymal hamartomaJ E Dickinson, S Knowles, J M Phillips
Journal of the American Geriatrics Society|August 12, 1999
Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective doseP A Rochon, G M Anderson, J V Tu, et al.
The British Journal of Dermatology|September 15, 2007
Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndromeM Tohyama, K Hashimoto, M Yasukawa, et al.
Regulatory Toxicology and Pharmacology : RTP|January 14, 2015
Utilizing relative potency factors (RPF) and threshold of toxicological concern (TTC) concepts to assess hazard and human risk assessment profiles of environmental metabolites: a case studyC Terry, R J Rasoulpour, S Knowles, et al.
Journal of Personality and Social Psychology|May 1, 1976
Personal space invasions in the lavatory: suggestive evidence for arousalR D Middlemist, E S Knowles, C F Matter
American Journal of Medical Genetics|June 1, 1991
Dandy-Walker malformation (variant), cystic dysplastic kidneys, and hepatic fibrosis: a distinct entity or Meckel syndrome?I R Walpole, J Goldblatt, A Hockey, et al.
The British Journal of Dermatology|March 20, 2014
Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded studyA J Kanwar, K Vinay, G U Sawatkar, et al.
Lancet (London, England)|April 22, 2008
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III studyK Papp, R Bissonnette, L Rosoph, et al.
Pageof 23